AA
ASBURY AUTOMOTIVE GROUP INC (ABG)·Q2 2025 Earnings Summary
Executive Summary
- Q2 2025 delivered mixed headline results: adjusted EPS of $7.43 beat Wall Street consensus ($6.86), while revenue of $4.373B modestly missed ($4.453B). EBITDA exceeded consensus, supported by strong Parts & Service and improving used retail GPUs (estimates marked with *; Values retrieved from S&P Global).
- Operational execution improved: SG&A as % of gross profit fell 198 bps YoY to 63.2% (adjusted 63.6%), with fourth consecutive sequential improvement in same‑store used retail GPU and record Parts & Service gross profit ($355M) .
- Strategic portfolio actions advanced: Asbury closed the Herb Chambers acquisition (valued at ~$1.45B; 2024 adjusted EBITDA $176.8M) and divested nine stores (net proceeds $250–$270M), increasing scale in a stable luxury‑heavy region while prioritizing leverage reduction over the next 12–18 months .
- Guidance updates: management now expects a 25.5% effective tax rate in Q3–Q4, ~$250M CapEx in both 2025 and 2026 (subject to tariff outcomes), continued SG&A in the mid‑60s for 2025, and full Tekion DMS conversion targeted by 2027; TCA deferral headwinds were $0.43/share in Q2 and timing has been revised with Koons rollout in early Q4 .
- Near‑term stock narrative hinges on tariff clarity and Herb Chambers integration; management expects new vehicle GPUs to trend toward $2,500–$3,000 over time (with optimism toward ~$3,000), a key margin watch item for investors .
What Went Well and What Went Wrong
What Went Well
- Record Parts & Service profitability: Parts & Service gross profit hit an all‑time high ($355M); same‑store gross profit up 7% with margin expansion (59.2%, +53 bps) .
- Used retail profitability: same‑store used retail gross profit per unit rose to $1,729 (+15% YoY), marking the fourth consecutive sequential improvement; front‑end yield held at $4,861 .
- Cost discipline: SG&A as % of gross profit improved to 63.2% (adjusted 63.6%); management reiterated focus on employee productivity and outside services, even while absorbing ~$2M Tekion implementation/testing costs .
- Management quote: “I commend our team members for their sustained focus on growth, profitability and cost discipline… we welcomed The Herb Chambers Automotive Group… entering a new region with a flagship group” .
What Went Wrong
- Top‑line softness vs consensus: revenue of $4.373B increased 3% YoY but missed Street ($4.453B*), with F&I PVR down 3% YoY to $2,084 and used retail units down 6% YoY .
- New vehicle margin pressure: total new vehicle gross margin fell to 6.9% (−22 bps YoY), with import/domestic GPU compression; management expects further normalization of new vehicle GPUs toward $2,500–$3,000 over time .
- TCA deferral headwind: non‑cash deferral reduced EPS by $0.43 in Q2; revised rollout timing (Koons in early Q4) shifts deferral cadence, adding forecasting complexity for near‑term EPS .
Financial Results
Headline vs Prior Periods and Estimates
- EPS: beat (Adjusted $7.43 vs $6.86*). Revenue: miss ($4,373.1M vs $4,453.2M*). EBITDA: beat (Adjusted $255.8M vs $250.9M*) .
- Q2 EBITDA (Company adjusted) $255.8M; Street EBITDA consensus $250.9M* .
Estimates disclaimer: Values retrieved from S&P Global.
Segment Breakdown (Q2 2025 vs Q2 2024)
KPIs
Guidance Changes
Earnings Call Themes & Trends
Management Commentary
- CEO on portfolio and execution: “We have taken strategic steps to optimize our portfolio… we welcomed The Herb Chambers Automotive Group… enter a new region… with a flagship group” .
- COO on used retail profitability: “Used retail gross profit per unit was $1,729… fourth quarter of sequential growth… we still plan to prioritize unit profitability” .
- CFO on EPS and TCA: “Adjusted EPS was $7.43… non‑cash deferral headwind due to TCA was $0.43 per share… adjusted EPS would have been $7.86 without the deferral” .
- CEO on Tekion: “When we're fully converted, which will hopefully be in 2027, is when we really recognize the SG&A benefits” .
- CFO on CapEx/leverage: “We anticipate approximately $250 million in CapEx for both 2025 and 2026… expect to be below the higher end of our [leverage] range in mid to late 2026” .
Q&A Highlights
- New vehicle GPUs and tariffs: management expects GPUs to normalize to $2,500–$3,000; tariff timing and OEM pricing adjustments will be key through the 2026 model year .
- SG&A drivers: focus on employee productivity and outside services; Tekion conversion and SOC controls added
$2M of Q2 costs ($1M implementation/duplication, ~$1M audit) . - Parts & Service outlook: comfort with mid‑single‑digit growth through 2H despite tougher warranty comps; CP and throughput support trajectory; warranty margins generally higher than CP .
- Herb Chambers integration: luxury‑weighted, stable New England market; scope to improve efficiencies over time; strategic defensive positioning .
- Capital structure: revolver lifted to $925M; new vehicle floor plan to $2.25B; divested nine stores ($250–$270M proceeds) to reduce leverage .
Estimates Context
- Q2 2025: Adjusted EPS beat ($7.43 vs $6.86*), Revenue missed ($4,373.1M vs $4,453.2M*), Adjusted EBITDA beat ($255.8M vs $250.9M*) (estimates marked with *; Values retrieved from S&P Global).
- Estimate revisions likely: higher parts & service profitability and lower SG&A underpin EPS upward bias; revenue trajectory depends on tariff impacts and F&I PVR; TCA deferral timing introduces near‑term EPS variability .
Key Takeaways for Investors
- EPS quality improving: cost discipline and Parts & Service strength drove an EPS beat vs consensus despite revenue softness; watch SG&A trajectory as Tekion costs phase and conversions progress .
- Margin watch: management’s GPU normalization path ($2.5k–$3k) suggests front‑end margin reversion; offset from Parts & Service margin expansion (59.2%) and used retail GPU improvements .
- Strategic scale: Herb Chambers adds ~$176.8M 2024 adjusted EBITDA and luxury skew in a stable region; integration plus divestitures support deleveraging over 12–18 months .
- Liquidity/Leverage: $1.1B liquidity and expanded facilities post‑deal provide flexibility; management targets leverage below the high end of the range by mid–late 2026 .
- TCA dynamics: Q2’s −$0.43/share deferral headwind and revised rollout timing can mask underlying performance short‑term; longer‑term EPS accretion from TCA remains intact per management .
- Tariff sensitivity: near‑term demand/pricing and F&I PVR bear monitoring; management expects OEM pricing adjustments with 2026 model year; narrative likely driven by tariff clarity and day‑supply stabilization .
- Technology execution: full Tekion conversion by 2027 should lower SG&A and improve efficiencies; early conversions incurred ~$2M in Q2 costs but feedback is positive .
Appendix: Additional Data Points
- Liquidity at Q2 end: $1.1B (cash/floorplan offset + availability), transaction‑adjusted net leverage 2.46x .
- Days supply: New 59; Used 37 at Q2 end .
- Brand mix (Q2 revenue): Luxury 30%; Imports 40%; Domestic 30% .
- TCA pre‑tax income: $7M; deferral impact −$11M (−$0.43/share) in Q2 .
Estimates disclaimer: Values retrieved from S&P Global.